Ubiquitin-mediated activation of TAK1 and IKK

被引:375
作者
Adhikari, A.
Xu, M.
Chen, Z. J. [1 ]
机构
[1] Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dept Mol Biol, Dallas, TX 75390 USA
[2] Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dept Mol Biol, Dallas, TX USA
基金
美国国家卫生研究院;
关键词
TAK1; IKK; ubiquitin; NF-kappa B; kinase;
D O I
10.1038/sj.onc.1210413
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Transforming growth factor beta activated kinase-1 (TAK1), a member of the mitogen-activated protein kinase kinase kinase family, has emerged as a key regulator of signal transduction cascades leading to the activation of the transcription factors nuclear factor-kappa B (NF-kappa B) and activator protein-1 (AP-1). Stimulation of cells with cytokines and microbial pathogens results in the activation of TAK1, which subsequently activates the I-kappa B kinase complex (IKK) and mitogen-activated protein (MAP) kinases, culminating in the activation of NF-kappa B and AP-1, respectively. Recent studies have shown that polyubiquitination of signalling proteins through lysine (Lys)-63-linked polyubiquitin chains plays an important role in the activation of TAK1 and IKK. Unlike Lys-48-linked polyubiquitination, which normally targets proteins for degradation by the proteasome, Lys-63-linked polyubiquitin chains act as scaffolds to assemble protein kinase complexes and mediate their activation through proteasome-independent mechanisms. The concept of ubiquitin-mediated activation of protein kinases is supported by the discoveries of ubiquitination and deubiquitination enzymes as well as ubiquitin-binding proteins that function upstream of TAK1 and IKK. Recent biochemical and genetic studies provide further insights into the mechanism and function of ubiquitin signalling and these advances will be the focus of this review.
引用
收藏
页码:3214 / 3226
页数:13
相关论文
共 125 条
  • [1] The Crohn's disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO
    Abbott, DW
    Wilkins, A
    Asara, JM
    Cantley, LC
    [J]. CURRENT BIOLOGY, 2004, 14 (24) : 2217 - 2227
  • [2] The trimerization domain of nemo is composed of the interacting C-terminal CC2 and LZ coiled-coil subdomains
    Agou, F
    Traincard, F
    Vinolo, E
    Courtois, G
    Yamaoka, S
    Israël, A
    Véron, M
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (27) : 27861 - 27869
  • [3] Signaling by proinflammatory cytokines: oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain
    Baud, V
    Liu, ZG
    Bennett, B
    Suzuki, N
    Xia, Y
    Karin, M
    [J]. GENES & DEVELOPMENT, 1999, 13 (10) : 1297 - 1308
  • [4] Identification of the familial cylindromatosis tumour-suppressor gene
    Bignell, GR
    Warren, W
    Seal, S
    Takahashi, M
    Rapley, E
    Barfoot, R
    Green, H
    Brown, C
    Biggs, PJ
    Lakhani, SR
    Jones, C
    Hansen, J
    Blair, E
    Hofmann, B
    Siebert, R
    Turner, G
    Evans, DG
    Schrander-Stumpel, C
    Beemer, FA
    van den Ouweland, A
    Halley, D
    Delpech, B
    Cleveland, MG
    Leigh, I
    Leisti, J
    Rasmussen, S
    Wallace, MR
    Fenske, C
    Banerjee, P
    Oiso, N
    Chaggar, R
    Merrett, S
    Leonard, N
    Huber, M
    Hohl, D
    Chapman, P
    Burn, J
    Swift, S
    Smith, A
    Ashworth, A
    Stratton, MR
    [J]. NATURE GENETICS, 2000, 25 (02) : 160 - 165
  • [5] The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses
    Boone, DL
    Turer, EE
    Lee, EG
    Ahmad, RC
    Wheeler, MT
    Tsui, C
    Hurley, P
    Chien, M
    Chai, S
    Hitotsumatsu, O
    McNally, E
    Pickart, C
    Ma, A
    [J]. NATURE IMMUNOLOGY, 2004, 5 (10) : 1052 - 1060
  • [6] Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB
    Brummelkamp, TR
    Nijman, SMB
    Dirac, AMG
    Bernards, R
    [J]. NATURE, 2003, 424 (6950) : 797 - 801
  • [7] Profound defect in T cell responses in TNF receptor-associated factor 2 dominant negative mice
    Cannons, JL
    Bertram, EM
    Watts, TH
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 169 (06) : 2828 - 2831
  • [8] TARF6 is a signal transducer for interleukin-1
    Cao, ZD
    Xiong, J
    Takeuchi, M
    Kurama, T
    Goeddel, DV
    [J]. NATURE, 1996, 383 (6599) : 443 - 446
  • [9] A MULTIUBIQUITIN CHAIN IS CONFINED TO SPECIFIC LYSINE IN A TARGETED SHORT-LIVED PROTEIN
    CHAU, V
    TOBIAS, JW
    BACHMAIR, A
    MARRIOTT, D
    ECKER, DJ
    GONDA, DK
    VARSHAVSKY, A
    [J]. SCIENCE, 1989, 243 (4898) : 1576 - 1583
  • [10] Site-specific phosphorylation of I kappa B alpha by a novel ubiquitination-dependent protein kinase activity
    Chen, ZJ
    Parent, L
    Maniatis, T
    [J]. CELL, 1996, 84 (06) : 853 - 862